IDEX Corporation acquired thinXXS Microtechnology AG for $38.2 million (cash) plus $1.2M assumed debt, a transaction completed in December 2017, structured as all cash (stock acquisition).
thinXXS Microtechnology AG operates in Health & Science Technologies, is based in Zweibrucken, Germany. Leader in the design, manufacture and sale of microfluidic components serving the point-of-care, veterinary and life science markets. Headquartered in Zweibrucken, Germany.
Acquired to complement IDEX's existing CiDRA Precision Services business and expand its microfluidic and nanofluidic capabilities.
Complements existing CiDRA Precision Services business and expands microfluidic and nanofluidic capabilities. Health & Science Technologies segment
On December 8, 2017, the Company acquired the stock of thinXXS Microtechnology AG (“thinXXS”), a leader in the design, manufacture, and sale of microfluidic components serving the point of care, veterinary, and life science markets.
Advisory firms were not disclosed for this transaction.